Loading…
Loading…
IQV · NYSE · Healthcare
“At twenty-one times earnings, you're paying a reasonable price for a company that helps drug makers navigate the regulatory maze better than most.”
— In the voice of Buffett
Determine what growth rate the market is pricing in. Compare implied growth against historical performance to identify mispricing.
Market Cap
$28.39B
P/E Ratio
20.88
Forward P/E
—
EPS
$7.91
PEG Ratio
0.87
Book Value
$37.83
Dividend Yield
—
Profit Margin
8.34%
ROE
20.91%
Use the interactive reverse dcf with pre-loaded data for IQVIA Holdings Inc. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for IQV: